Lonvo-z is an in vivo CRISPR gene editing candidate that is designed to inactivate the kallikrein B1 gene, thereby permanently lowering kallikrein and bradykinin levels.
A new wave of the Glassworm campaign is targeting the OpenVSX ecosystem with 73 "sleeper" extensions that turn malicious ...